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Background: Immune responses are generally impaired in aged mammals. T cells have been extensively studied in
this context due to the initial discovery of their reduced proliferative capacity with aging. The decreased responses
involve altered signaling events associated with the early steps of T cell activation. The underlying causes of these
changes are not fully understood but point to alterations in assembly of the machinery for T cell activation. Here,
we have tested the hypothesis that the T cell pool in elderly subjects displayed reduced functional capacities due
to altered negative feedback mechanisms that participate in the regulation of the early steps of T cell activation.
Such conditions tip the immune balance in favor of altered T cell activation and a related decreased response in
aging.
Results: We present evidence that the tyrosine phosphatase SHP-1, a key regulator of T cell signal transduction
machinery is, at least in part, responsible for the impaired T cell activation in aging. We used tyrosine-specific mAbs
and Western blot analysis to show that a deregulation of the Csk/PAG loop in activated T cells from elderly individuals
favored the inactive form of tyrosine-phosphorylated Lck (Y505). Confocal microscopy analysis revealed that the
dynamic movements of these regulatory proteins in lipid raft microdomains was altered in T cells of aged individuals.
Enzymic assays showed that SHP-1 activity was upregulated in T cells of aged donors, in contrast to young subjects.
Pharmacological inhibition of SHP-1 resulted in recovery of TCR/CD28-dependent lymphocyte proliferation and IL-2
production of aged individuals to levels approaching those of young donors. Significant differences in the active (Y394)
and inactive (Y505) phosphorylation sites of Lck in response to T cell activation were observed in elderly donors as
compared to young subjects, independently of CD45 isoform expression.
Conclusions: Our data suggest that the role of SHP-1 in T cell activation extends to its increased effect in negative
feedback in aging. Modulation of SHP-1 activity could be a target to restore altered T cell functions in aging. These
observations could have far reaching consequences for improvement of immunosenescence and its clinical
consequences such as infections, altered response to vaccination.
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Aging is generally associated with an impairment of the
immune response, a phenomenon globally referred to as
immunosenescence [1-4]. For instance, there is reduced
production of IL-2 and impaired proliferation of T lym-
phocytes of elderly individuals [5], as well as a series of
altered signaling events associated with the early steps of
T cell activation reviewed in [6,7]. Immunosenescence is
observed even in healthy aged individuals [8] and has
been shown to affect the innate and adaptive arms of the
immune response [9,10]. Although the mechanism of
immunosenescence remains not fully understood, it has
been clearly established that T cells of aged individuals
display reduced clonal expansion that translates into
increased susceptibility to infectious diseases [11], im-
paired responses to vaccination, [12,13], increased sus-
ceptibility to cancer [6,7,14,15] and autoimmune diseases
[2,16-18] and, chronic inflammatory diseases such as
Alzheimer’s disease and atherosclerosis [19,20].
T cell activation involves initial recognition of antigenic
epitopes presented by professional APC within the context
of MHC class I or class II molecules. Close contact between
T cells and APC results in assembly of a supramolecular
structure called the immune synapse (IS) [21-23]. IS forma-
tion is modulated through dynamic movements of lipid
rafts [24-26] that facilitate local clustering of the essential
components of T cell signaling [27]. Interactions between
TCR and epitope-loaded MHC I or II and with CD8 or
CD4 respectively, provide the first signal that leads to a cas-
cade of events resulting from the assembly of the signal
transduction machinery or signalosome [28]. However, a
second signal has to be provided by occupation of co-
stimulation molecules of activation [29-33]. Combination
of TCR and CD28 signaling results in full T cell activation
characterized by gene expression, cytokine production, cell
proliferation, clonal expansion and, generation of effector
and memory functions [28].
From a biochemical standpoint, one of the first events
that follow engagement of the TCR by epitope-loaded
MHC is the CD45-dependent removal of the phosphate
group on tyrosine residue 505 (Y505) of the p56Lck (Lck)
Src kinase [34]. Dephosphorylation relieves its cAMP-
regulated [35] Csk-dependent inhibition and allows its
auto/trans-activation [36]. Activated Lck then targets the
TCR-associated ζ homodimer that provide sites for re-
cruitment and activation of the SH2 domain-containing
ZAP-70. Activated ZAP-70 tyrosine-phosphorylates se-
veral constituents of the signalosome, including scaffold
and adaptor proteins, protein and lipid kinases which
are essential for Ca2+ mobilization [37] and activation
of the p21Ras (Ras)/MAP kinase and NF-AT pathways
[28,38,39]. On the other hand, engagement of CD28 trig-
gers activation of the NF-κB pathway [40,41]. These acti-
vated pathways converge to allow nuclear translocationof the transcription factors AP1, NF-AT and NF-κB and,
initiation of expression of a number of genes, including
IL-2 and its receptor which are essential for T cell prolif-
eration [42]. Whereas this series of events works in a
forward direction to trigger T cell activation and protec-
tion against antigenic aggression, complex mechanisms of
T cell regulation of activation also operate to prevent un-
controlled responses and autoimmunity and/or immune
catastrophe [43,44]. A number of early cytoplasmic com-
ponents including protein kinases and phosphatases and,
adaptor proteins also act as negative feedback regulators
of the TCR signalosome [28,44]. A key target for the
negative regulation of T cell signaling is Lck. Lck activity is
finely tuned by a complex of proteins comprising plasma
membrane-embedded protein tyrosine phosphatase CD45
and cytoplasmic protein tyrosine kinase Csk bound to
scaffold protein PAG (CBP), and to adaptor protein TSAD
[45,46]. In addition, cytoplasmic phosphatases SHP-1 and
Lyp (PTPN22) are thought to play a role in the regulation
of Lck activity [28,47-49]. Many of the components of
the signaling machinery of T cell activation are targets of
SHP-1. For instance, SHP-1 removes key phosphate
groups on tyrosine residues of Lck [48] and ZAP-70 and
that results in loss of activity of these essential protein
kinases [50,51]. Furthermore, this regulatory loop of Lck
can discriminate between self and non-self as weakly bind-
ing ligands predominantly trigger a negative feedback loop
leading to rapid recruitment of the tyrosine phosphatase
SHP-1, followed by receptor desensitization through
inactivation of Lck while, strongly binding ligands effi-
ciently activate a positive feedback circuit involving Lck
modification by ERK, preventing SHP-1 recruitment
and allowing the long-lasting signaling necessary for
gene activation [52,53].
Beside decreased IL-2 production and T cell prolifera-
tion, we and others have shown that the composition
and function of lipid rafts were altered with aging [54]
and that the activation of Lck, Fyn, ZAP70 and LAT was
impaired [55,56]. Overall, these observations were con-
sistent with the interpretation that T cell activation and
early events in T cell signaling were altered in aged in-
dividuals [7]. However, our data did not exclude the
possibility that negative regulation of T cell activation
through actions of protein tyrosine phosphatases or
other mechanisms were also altered. Recently, it has
been shown that by modulating later signaling events by
phosphatases especially by the DUSP6 repression using
miR-181a or specific siRNA and DUSP6 inhibition im-
proved CD4 T cell responses, as evidenced by increased
expression of activation markers, improved proliferation
and supported preferential T helper type 1 cell diffe-
rentiation [57,58]. Here, we report that a deregulation of
the Csk/PAG/CD45 loop in T cells of elderly subjects favors

































Figure 1 Western blot analysis of the levels of tyrosine-
phosphorylated (Y505) Lck. (A) Purified T cells from young and
elderly donors were left non-stimulated (NS) or exposed to a mixture
of anti-CD3 (5 μg/ml) and anti-CD28 (5 μg/ml) mAbs for 30 s or 5 min,
as indicated. Cell lysates were sized by SDS-PAGE under reducing
conditions, electrotransfered to nitrocellulose membranes and
proteins revealed using appropriate mAbs and the chemiluminescence
technique. β-Actin was used as control of gel loading. The protein
transferred to nitrocellulose membranes were stained with Ponceau
to verify that similar amounts of protein had been loaded in each
lane. (B) Time-related Y505-phosphorylated Lck analyzed by
semi-quantitative densitometry and reported in arbitrary units in the
case of stimulated (anti-CD3/anti-CD28, 5 μg/ml each) T cells of young
(filled columns) and elderly (empty columns). Data are represented as
the mean ± SD. Asterisks correspond to statistical significance (Student’s
t-test) for p < 0.05 (*) and p < 0.01 (**). Data are representative of one of
20 independent experiments.
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activity and alterations in the dynamic movements of
signaling proteins in lipid rafts. Of significance, pharma-
cological inhibition of SHP-1 resulted in recovery of
TCR/CD28-dependent lymphocyte proliferation and IL-
2 production in PBMCs of aged individuals. Our data
suggest that the regulatory role of SHP-1 in the forward
direction of T cell activation through TCR and CD28 ex-
tends to its involvement as negative feedback regulator
of Lck activity in aging.
Results
Differential levels of pLck (Y505) in T cells of young
and aged subjects
We have reported that T cell responses of elderly sub-
jects are impaired at the early proximal steps of T cell
activation [6,7], including Lck phosphorylation on Y394
[55]. We hypothesized that the data could be explained
by a negative feedback through protein kinases and
phosphatases that could play a suppressive role in aging
[7]. Whereas a fraction of Lck is in a primed/activated
state in T cells [59,60], a major fraction of the kinase is
maintained in an inactive state as a result of Csk-
dependent phosphorylation of a single tyrosine residue
(Y505) located in the C-terminal region. This modifica-
tion allows the kinase to fold into a closed, inactive
conformation [60]. The balance between the different
activation states and distribution in plasma membrane
microdomains of Lck allows efficient TCR signal transduc-
tion in T cells [49,59,60]. Here, we have measured the
time-dependent levels of pLck-Y505 in purified T lympho-
cytes of young and elderly subjects activated through
CD3-CD28. Western blots (Figure 1A) showed that the
levels of pLck-Y505 rapidly decreased (30 s) following acti-
vation of T cells of young individuals (p < 0.01) and still
remained significantly lower compared to initial levels
5 min after activation (p < 0.05) Figure 1A and B). In con-
trast, the levels of inactive pLck-Y505 in T cells of elderly
subjects slightly, but not significantly decreased over the
course of the experiment (Figure 1A and B) suggesting a
lack of modulation of pLck-Y505 during T cell activation.
Protein levels of Lck are not different between young
and elderly subjects and did not change during the
course of the experiments. Similar results were obtained
by Flow Cytometry (data not shown). Early changes
(30 s) observed in young individuals were absent in the
case of T cells from elderly. Further gating on CD45RA
versus CD45RO T cells of young and elderly subjects
did not reveal significant differences for pLck status
inside of the age-groups (data not shown). The bulk
of these data suggested a differential regulation of Lck
in T lymphocytes of young and elderly subjects that de-
pends on the T cell population but not on the CD45RA
or CD45RO subpopulations.Involvement of PAG phosphorylation in age-related T cell
signaling dysfunction
In T cells, phosphorylation of PAG creates docking sites
for the SH2 domain-containing protein tyrosine kinase
Csk and that enables its recruitment to the plasma mem-
brane. Csk then negatively regulates Src family members
Lck and Fyn activity through tyrosine phosphorylation at
their C-terminus [46]. Conversely, stimulation of T lym-
phocytes induces CD45 and other phosphatase-dependent
dephosphorylation of pPAG [61], followed by the release
of Csk from its proximity with Lck, thus facilitating activa-
tion of Lck [62]. In consequence, we have measured the
time-dependent levels of pPAG in stimulated lymphocytes
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vealed a sustained slow decrease of PAG phosphorylation
from resting levels in T cells of young subjects following ac-
tivation (p < 0.01 at 30 s and p < 0.05 at 5 min) (Figure 2A
and B). In contrast, the levels of pPAG in T cells of elderly
donors were higher than those of young donors in the rest-
ing state (p < 0.01) and remained elevated following ligation
of CD3-CD28 (p < 0.01) (Figure 2A and B). These observa-
tions brought additional support to the interpretation that
Lck was differentially regulated in T lymphocytes of young
and elderly subjects, likely through differential modulation
of the levels of pPAG.
Lipid raft distribution of pPAG and Csk in T cells of young
and aged donors
We have reported that lipid raft functions are altered with
aging [56,63]. Here, we sought to determine whether the





























Figure 2 Western blot analysis of the levels of tyrosine-
phosphorylated PAG. (A) Purified T cells from young and elderly
donors were left non-stimulated (NS) or exposed to a mixture of
anti-CD3 and anti-CD28 (5 μg/ml each) mAbs for 30 s or 5 min, as
indicated. Cell lysates were sized by SDS-PAGE under reducing
conditions, electrotransfered to nitrocellulose membranes and proteins
revealed using appropriate mAbs and the chemiluminescence
technique. β-Actin was used as control of gel loading. The protein
transferred to nitrocellulose membranes were stained with Ponceau
to verify that similar amounts of protein had been loaded in each
lane. (B) Protein bands were analyzed by semi-quantitative
densitometry and are reported in arbitrary units. Results of T cells
of young (filled columns) and elderly (empty columns) donors are
shown. Data are represented as the mean ± SD. Asterisks correspond to
statistical significance (Student’s t-test) for p < 0.05 (*), p < 0.01 (**). Data
are representative of one of 20 independent experiments.donors. Results showed that pPAG was almost equally
located in the lipid raft (LR) and non-lipid raft (NLR)
fractions of resting T cells of young subjects (Figure 3A
and B). Its distribution to LR significantly decreased
30 s following T cell activation (p < 0.05) without any
change in the NLR fraction but returned to resting
levels 5 min later (Figure 3A and B). The levels of pPAG
in the lipid raft fraction of T cells from aged donors
were lower than in young subjects in the resting state
(p < 0.05) (Figure 3A and B). Surprisingly, ligation of
CD3-CD28 did not trigger the expected pPAG down-
regulation in lipid rafts (Figure 3A and B) and even an
increased pPAG localization is observed mainly at 30 s
(p < 0.05). This is in sharp contrast to what was ob-
served in T cells of young subjects.
Csk has been reported to transiently migrate out of
lipid rafts following TCR engagement [61] concomitantly
with pPAG migration out of lipid rafts. Confocal micros-
copy analysis showed that approximately 70% of Csk co-
localized in lipid rafts of resting T cells of young donors
(Figures 3C). Its distribution in lipid rafts decreased sig-
nificantly (p < 0.006) 30 s after ligation of CD3-CD28
and it remained out of lipid rafts over the course of the
experiments, without significant differences (Figures 3C).
In marked contrast in the case of aged donors, Csk
distribution in resting T cells is less abundant inside
LR (Figure 3D). Activation through CD3-CD28 did not
result in Csk migration in/out of lipid rafts and its dis-
tribution remained nearly unchanged over the course
of the experiments (Figures 3D).
CD45, CD45RA And CD45RO expression, activity in T cells
with aging
CD45 is a type I transmembrane protein tyrosine phos-
phatase that can act as a positive and a negative regulator
of TCR signal transduction, depending on the nature of
the stimulus [62,64]. First, we used an Ab that recognized
all the alternatively spliced isoforms of CD45 (Figure 4A
first row). Results (Western blots) showed that the ex-
pression of CD45 was lower in resting T cells of young
subjects compared to elderly individuals when normalized
over β-actin (Figure 4B, p < 0.01) and remained relatively
unchanged over the course of the experiments. The
immunoprecipitated CD45 activity was measured and
found to be similar in the resting states of T cells of both
groups of donors but was significantly higher in T cells of
aged donors, 30 s (p < 0.05) and 30 min (p < 0.01) follow-
ing activation (Figure 4B, right panel). In young subjects
the CD45RA/CD45RO T cell ratio was higher (p < 0.01)
than in T cell of elderly subjects (Figure 4C, top panel),
which is expected based on the higher frequency of mem-
ory cells (identified as CD45RO-expressing cells). We also
measured the activity of the immunoprecipitated CD45RA
and CD45RO. It was found that their activities did not





























































Figure 3 Western blot and confocal analysis of Csk and tyrosine-phosphorylated PAG in plasma membrane lipid rafts (LR). (A) Purified
T cells were left non-stimulated (NS) or exposed to a mixture of anti-CD3 and anti-CD28 (5 μg/ml each) mAbs for various periods of time, as
indicated. Cell lysates were separated on sucrose density gradients and fractions corresponding to lipid rafts (LR) and non-lipid rafts (NLR) were
isolated, sized by SDS-PAGE under reducing conditions, electrotransfered to nitrocellulose membranes and proteins revealed using appropriate mAbs
and the chemiluminescence technique. β-Actin was used as control of gel loading. The protein transferred to nitrocellulose membranes were stained
with Ponceau to verify that similar amounts of protein had been loaded in each lane. (B) Protein bands were analyzed by semi-quantitative densitometry
and are reported in arbitrary units. Results of T cells of young (filled columns) and elderly (empty columns) donors are shown. Data are represented as
the mean ± SD. Asterisks indicate statistical significance (Student’s t-test) for p< 0.05. (C and D) Confocal analysis of the distribution in lipid rafts of cholera
toxin B subunit (CTx) and Csk of resting (NS) and T cells activated (TCR-CD28) for various periods of time, as indicated. An illustrative example of young
(C) and elderly (D) individual, merged images and masking are shown. Data are representative of one of a minimum of 12 independent experiments.
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points. (Figure 4C, bottom and middle panels, respect-
ively). Thus, the increased enzymatic activity of total
CD45 in elderly donors reflects the increased expression
of CD45RO. We made a Ponceau to determine that at all
measurement points the immunoprecipitated protein
amount was the same. Data for these latter experiments
were carried out on isolated T cells from 5 independent
subjects in each age group in triplicate. Confocal micros-
copy experiments showed that CD45 location to lipid rafts
in T cells of young and elderly donors remained respect-
ively unchanged over the course of the experiments (data
not shown).
Expression, activity and distribution of phosphorylated
SHP-1 in T cells with aging
SHP-1 is a cytoplasmic tyrosine phosphorylation-regulated
protein phosphatase that displays negative regulatory effects
on T cell activation. Whereas phosphorylation of Tyr536
increases its activity several folds [65], phosphorylation of
S591 decreases its activity [66]. Here, Western blot analysis
showed that pSHP-1 (Y536) levels in T cells of youngsubjects decreased significantly at 30 s following activation
through CD3-CD28 stimulation (p < 0.01) compared to the
resting state, and returns to original levels (Figure 5A
and B), suggesting that TCR stimulation transiently but
significantly decreases its activity. In marked contrast,
the levels of pSHP-1 (Y536) in T cells of elderly donors
were elevated in the resting state and remained high
30 s and 5 min after stimulation (Figure 5A and B)
indicating that no modulation occurred in T cells after
TCR stimulation. These results were confirmed by Flow
Cytometry analysis (Figure 5C). The mean fluorescence
intensity (MFI) of the phospho-SHP1 was normalized to
100% for the resting T cells from young and elderly and
the corresponding MFI for activated cells (30 s) is shown.
As in the WB experiments, there is a significant decrease
(p < 0.01) in pSHP-1 in T cells from young subjects whereas
almost no change was observed in elderly subjects
(Figure 5C). Although SHP-1 activity in immunopre-
cipitates was not significantly different between young
and elderly donors in the resting state (Figure 5D),
the SHP-1 activity was significantly increased (2.7-fold)



















Figure 4 Western blot analysis and measurement of CD45 and CD45RA and CD45RO activities. (A) Purified T cells from young and elderly
donors were left non-stimulated (NS) or exposed to a mixture of anti-CD3 and anti-CD28 (5 μg/ml each) mAbs for various periods of time, as
indicated. Cell lysates were sized by SDS-PAGE under reducing conditions, electrotransfered to nitrocellulose membranes and proteins revealed
using an anti-CD45 mAb and the chemiluminescence technique. β-Actin was used as control of gel loading. The protein transferred to nitrocellulose
membranes were stained with Ponceau to verify that similar amounts of protein had been loaded in each lane. (B) Results of T cells of young (empty
columns) and elderly (filled columns) donors are shown. Protein bands were analyzed by semi-quantitative densitometry and are reported in
arbitrary units. Left panel shows the CD45/β-actin expression (**, p < 0.01), and right panel shows CD45 activity, in optical density units, of T cell
lysate immunoprecipitates determined using 4-nitrophenyl phosphate as a substrate. Results of T cells of young (filled columns) and elderly
(empty columns) donors are shown. (C) The CD45RA/CD45RO ratio in T cells from young and elderly is shown (top panel). CD45RO activity
(middle panel) and CD45RA activity (bottom panel) shown in optical density units in T cell lysate immunoprecipitates determined using
4-nitrophenyl phosphate as a substrate. Results of T cells of young (filled columns) and elderly (empty columns) donors are shown. The protein
transferred to nitrocellulose membranes were stained with Ponceau to further verify that similar amounts of protein had been measured for each point
of activity. Data are represented as the mean ± SD. Asterisks correspond to statistical significance (Student’s t-test) for p< 0.05 (*) and p< 0.01 (**). Data
are representative of one of 20 independent experiments.
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(Figure 5D). It is of note that in line with SHP-1 de-
creased tyrosine phosphorylation the SHP-1 activity sig-
nificantly decreased in T cells at 30 sec after stimulation
(p < 0.05), while instead increased in T cells of elderly
donors. There were no differences at 5 min between the
two groups of donors (Figure 5C). Extending the obser-
vations to 30 min revealed that SHP-1 activity returned
to basal levels in T cell lysates of young subjects but
SHP-1 activity was still 1.8-fold higher in the case of
elderly subjects (p < 0.01) (Figure 5C).
SHP-1 is partially located in lipid rafts in murine thymo-
cytes and T cell lines [50] and retained in lipid rafts of
human neutrophils of elderly donors [67]. Here, SHP-1was detected to the same extent in lipid rafts of T cells of
young and elderly individuals in the resting state (Figure 6A
and B). Activation of the cells triggered a significant de-
crease of SHP-1 localization in lipid rafts at 30 s in the case
of both groups of donors, however this was more import-
ant in the case of young subjects (p < 0.01) compared to
elderly subjects (p < 0.05), followed by recruitment back to
lipid rafts (5/30 min) (Figure 6A and B).
Inhibition of SHP-1 leads to recovery of TCR/CD28-dependent
proliferative response and IL-2 production in T cells of aged
individuals
A key feature of altered T cell responses of elderly subjects































































Figure 5 Western blot analysis of the levels of (active) tyrosine-phosphorylated (Y536) SHP-1. (A) Purified T cells of young and elderly
donors were left non-stimulated (NS) or exposed to a mixture of anti-CD3 and anti-CD28 (5 μg/ml each) mAbs for 30 s or 5 min, as indicated. Cell
lysates were sized by SDS-PAGE under reducing conditions, electrotransfered to nitrocellulose membranes and proteins revealed using an anti-Y536
SHP-1 mAb and the chemiluminescence technique. β-Actin was used as control of gel loading. The protein transferred to nitrocellulose membranes
were stained with Ponceau to verify that similar amounts of protein had been loaded in each lane. (B) Semi-quantitative densitometric analysis of
protein bands of young (filled columns) and elderly (empty columns) donors reported in arbitrary units. Data are represented as the mean ± SD and
are representative of one of 20 independent experiments. (C) Flow cytometry measurements of pSHP-1-Y536 MFI in T cells of young and elderly subjects
at non-stimulated (NS) and stimulated for 30 seconds (S) states as decribed in the Materials and Methods section. The non-stimulated is normalized as
100% and significant difference is shown by **, p < 0.01. (D) Determination of SHP-1 activity in T cell lysate immunoprecipitate using 4-nitrophenyl
phosphate as a substrate. Data show results of T cells of young (filled columns) and elderly (empty columns) donors reported in optical density units. Data
are represented as the mean ± SD. Asterisks correspond to statistical significance (Student’s t-test) for p < 0.05 (*), p< 0.01 (**) and p< 0.001 (***). Data are
representative of one of 20 independent experiments.
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sented above suggested that the modulation of SHP-1 ac-
tivity could have a positive influence on T cell proliferation
isolated from elderly donors. T cells of both groups of
donors were left untreated or treated with a SHP-1 in-
hibitor (PTP-1) also known to inhibit the PTP1B which is
involved in the insulin signaling pathway. We tested prolif-
eration in response to a combination of anti-CD3 and
anti-CD28 mAbs. Results showed that the proliferation of
T cells of elderly donors in the absence of PTP-1 wassignificantly decreased (53.8%) in response to stimulation
through the CD3-CD28 pathways as compared to young
donors (Figure 7A). Lymphocyte response to polyclonal
PHA activation was also decreased (64.8%) in the case of
aged donors, as reported [5]. However, treatment of the
cells with PTP-1 (50 ng/ml) for 30 s resulted in a partial
but significant restoration (1.35-fold) of T cell prolifera-
tion of elderly donors, which raised the proliferative re-
sponse to levels not significantly different from that of








































Figure 6 Confocal analysis of the distribution of SHP-1 in plasma membrane lipid rafts. (A) Analysis of the distribution in lipid rafts of
cholera toxin B subunit (CTx) and SHP-1 of non-stimulated (NS) and activated (anti-TCR/anti-CD28 mAbs, 5 μg/ml each) T cells of young and
elderly donors for various periods of time. An illustrative example of individual, merged images and masking is shown. (B) Colocalization data
showing results of T cells of young (filled columns) and elderly (empty columns) donors. Data are represented as the mean ± SD of pixel intensities
determined by masking. The asterisks indicate significance (Student’s t-test) for p < 0.05 (*) and p < 0.01 (**). Data are representative of one of
20 independent experiments.
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when the cells had been exposed to PTP-1 for 30 min and
was not different than that observed in the case of T cells of
young donors treated with PTP-1 for 30 s (Figure 7A).
We next sought to determine whether the recovery of
T cell proliferation of aged donors correlated with in-
creased intracellular production of IL-2. Results from
flow cytometry experiments showed an increase in the
percentage of IL-2-producing T cells of young and elderly
subjects measured 3 h, 6 h and 24 h after CD3-CD28
stimulation (Figure 7B). The percentage of IL-2-positive
stimulated T cells of young donors was significantly higher
than in the case of aged donors at 3 h and 6 h but was
similar after 24 h of stimulation (Figure 7B). A brief (30 s)
treatment with PTP-1 did not induce T cells of elderly do-
nors to produce IL-2 to the same extent as T cells of
young donors at 6 h only (p < 005). However, the presence
of the SHP-1 inhibitor resulted in significant increases in
the percentage of IL-2-positive T cells with respect to the
absence of inhibitor in stimulated T cells of aged donors at
3 h, 6 h and 24 h following activation (Figure 7B). A simi-
lar effect was observed in T cells of young donors except
at 3 h. Extended exposures to PTP-1 (30 min) resulted
in IL-2 production that was not significantly differentbetween the two groups of donors when measured 3 h,
6 h and 24 h following T cell stimulation (Figure 7B).
Effect of SHP-1 inhibition on Lck phosphorylation in T
lymphocytes of young and elderly individuals
We assessed the time-dependent levels of active (Y394)
and inactive (Y505) forms of pLck in response to stimu-
lation through CD3-CD28 in T cells of young and elderly
donors exposed or not to PTP-1. Western blot analysis
showed that the elevated levels of Lck-Y505 in resting
cells of young donors decreased rapidly 30 s after activa-
tion (p < 0.05), then steadily increased 5 and 30 min later
(Figure 8A and B). As expected, the levels of pLck-Y394
were low in resting cells of young donors, rapidly in-
creased 30 s and 5 min after activation and remained
significantly sustained for the next 30 min (p < 0.01)
(Figure 8A and B). Treatment with the PTP-1 did not
appear to further increase the activated form (Y394) of
Lck when assessed 30 s and 30 min after T cell activa-
tion, suggesting that the optimal activation of early sig-
naling through CD3-CD28 stimulation could not be
further modulated. In this context, it is to be noted that
the inactive form (Y505) of pLck was less sensitive to
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Figure 7 Proliferation and interleukin-2 production in PBMCs exposed to the SHP-1 inhibitor PTP-1. (A) PBMCs were isolated from young
(filled columns) and elderly (empty columns) donors, left untreated or exposed to the SHP-1 inhibitor PTP-1 (50 ng/ml) for the indicated times.
The cells were non-stimulated (NS) or cultured in the presence of a mixture of anti-CD3 and anti-CD28 (5 μg/ml each) mAbs, or PHA (5 μg/ml)
for 72 h. Cell proliferation was assayed by incorporation of [3H]thymidine. Data are represented as the mean ± SD. Letter (a) corresponds to statistical
significance (one way ANOVA) for p < 0.05. Non-significance was observed for data relative to results obtained in PBMCs stimulated in the absence of
PTP-1. Data are representative of one of 9 independent experiments using different donors. (B) Similar conditions of PBMCs treatment in the absence
or presence of the inhibitor (I) PTP-1 with the mixture of anti-CD3/anti-CD28 (5 μg/ml each) mAbs or a combination of PMA (50 ng/ml) and ionomycin
(iono) (1 ng/ml) were performed for the periods of time indicated. The extent of IL-2 production in non-stimulated (NS) or stimulated T cells
was determined by FACS analysis of permeabilized cells using a FITC-labelled anti-Il-2 mAb. Results obtained in the case of young and elderly
donors are shown using filled and empty columns, respectively. Letter (b) corresponds to statistical significance (one way ANOVA) for p < 0.05.
Data are representative of one of 5 independent experiments.
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namic in activated T cells of aged donors was vastly dif-
ferent. Whereas the levels of inactive pLck-Y505 were
elevated in resting cells, they very slowly but significantly
decreased (p < 0.05) over time after activation (Figure 8A
and B) to remain steady 5 and 30 min after activating
the cells. The levels of active pLck (Y394) did not
change 30 s after stimulating the cells as compared to
resting cells (Figure 8A and B). There was a decrease at
5 min, followed by an increase at 30 min. The presence
of PTP-1 significantly increased the levels of activated
pLck (Y394) very early (30 s) following T cell activation
(p < 0.01) (Figure 8A and B) showing that inhibition of
SHP-1 can modulate the positive activation of Lck in aged
donors. Differences between lymphocyte responses to acti-
vation were further revealed by doing a ratio between the
two phosphorylated forms of Lck in activated T cells with
respect to resting cells. This approach showed that the ra-
tio of pLck-Y505 was low in resting cells of young donors
and remained relatively low over the time of experiments,
even after prolonged (30 min) activation (Figure 8C). As
expected, T cell activation resulted in a rapid increase of
the ratio of pLck-Y394 after 30 s which was further in-
creased after 5 min but which decreased after prolonged(30 min) activation (Figure 8C). Treatment with PTP-1
maintained the active form of Lck over time (Figure 8C).
A significantly different pattern of pLck behavior was ob-
served in the case of aged donors (Figure 8D). In this case,
the levels of inactive and active Lck were low under all ex-
perimental conditions, suggesting a sluggish and altered
response in T cells activated through CD3-CD28 in aged
donors. However, the presence of PTP-1 favored Lck acti-
vation only after 30 s of stimulus in the case of elderly
subjects (Figure 8D).
Discussion
Here, we have tested the hypothesis that the T cell pool in
elderly subjects displayed reduced functional capacities
due to altered negative feedback mechanisms that are in-
volved in the regulation of the early steps of T cell activa-
tion. Data presented here are based on purified T cells and
total T cell populations of young and elderly individuals.
Immune responses become less efficient as humans get
older and this phenomenon contributes to the overall state
of immunosenescence. In this connection, accumulated
data [36,40,41,68] have established that Lck is a pivotal
regulator of the TCR- and CD28-associated early events of
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Figure 8 Western blot analysis of the levels of Y505- and Y394-phosphorylated forms of Lck in untreated and PTP-1-treated T cells.
(A) T cells were left non-stimulated (NS) or exposed to a mixture of anti-CD3 and anti-CD28 (5 μg/ml each) mAbs for the times indicated, in the
absence of the SHP-1 inhibitor (I) PTP-1 or its presence (50 ng/ml). Cell lysates were sized by SDS-PAGE under reducing conditions, electrotransfered to
nitrocellulose membranes and proteins revealed using relevant mAbs and the chemiluminescence technique. β-Actin was used as control of gel loading.
The protein transferred to nitrocellulose membranes were stained with Ponceau to verify that similar amounts of protein had been loaded in each lane.
(B) Densitometric semi-quantification of the data, shown in arbitrary units in the case of young and elderly donors. For sake of clarity, significant statistical
differences are indicated with filled circles (●, pLck-Y505) or filled squares (■, pLck-Y394) with respect to resting cells in the case of young donors. In the
case of elderly donors, significant statistical differences are indicated with filled diamonds (♦, pLck-Y505) or ddags (‡, pLck-Y394) with respect to resting
cells. (C and D) Densitometric ratio with respect to resting cells were determined for the various times and conditions of experiments for young (C) and
elderly (D). Data are representative of one of 15 independent experiments.
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here provide evidence that SHP-1 exerts a greater negative
feedback effect on Lck-mediated activation of T lympho-
cytes of aged humans than in T cells of young individuals.
This accrued effect of Lck in aging may, at least in part, be
responsible for the characteristic impaired proliferation of
these cells in response to stimulation.
The levels of the inactive phosphorylated form (Y505)
of Lck relative to total Lck were moderate in the resting
state of T cells of young donors, as reported in T cells
and the Jurkat T cell line [69]. The levels of pLck (Y505)
decreased over time of stimulation, suggesting that the
levels of inactive kinase decreased presumably at the ex-
pense of the active form. In marked contrast, the levels
of Lck Y505 only slightly decreased over the time course
of stimulation in the case of elderly individuals, suggest-
ing a lack of modulation or maintenance of the inhi-
bitory status of Lck. This differential behavior of T cellresponse in young and elderly donors suggested an alter-
ation of T cell regulation in the control loop of Lck acti-
vation involving the PAG-Csk complex [35,46,61] in
elderly subjects. An alternative but not exclusive inter-
pretation was an alteration in the efficiency of CD45 to
remove the phosphate group at position Y505 of Lck.
Engagement of TCR triggers dephosphorylation of PAG
and the subsequent migration of Csk out of the lipid
rafts, a situation which facilitates CD45-dependent re-
moval of the phosphate group on Y505 [70] and pLck-
Y394 upregulation. We showed here that several aspects
of the PAG/Csk regulation loop were altered in T cells
of elderly subjects. First, Western blot analysis clearly
showed that the levels of pPAG were elevated in resting
T lymphocytes of elderly subjects and remained at
higher levels than those observed in young donors over
the course of the experiments (Figure 2). These observa-
tions suggested that in T cells of aged subjects, the
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phorylated form, in agreement with the results of Western
blots (Figures 1A). Second, this interpretation was fur-
ther supported by analysis of location of pPAG in lipid
rafts which clearly showed a differential distribution in
T cells of elderly and young individuals (Figure 3). Kin-
etically, pPAG migrated out of lipid rafts in response to
stimulation in the case of T cells of young donors but
the levels of pPAG in lipid rafts remained unchanged in
resting and activated T cells of aged donors (Figure 3).
The inability of pPAG to migrate out of lipid raft micro-
domains in the case of T cells of aged donors was likely
related to the reported decreased function of lipid rafts
of T cells of elderly individuals due to the increased
cholesterol level [54]. Our data fit current models
[28,68,71] whereby TCR/CD28 activation induces cellu-
lar phosphatases to dephosphorylate Csk-associated
pPAG (Y317) during concurrent trafficking out of lipid
rafts, resulting in the release of Csk to the cytoplasm.
Interruption of Csk-pPAG association results in abrupt
decline of phosphorylated (Y505) Lck. Our data showed
differential levels of pLck (Y505) in young and elderly
subjects that explained the decreased response in T cells
of aged individuals [55].
CD45 activity controls the upregulation of Lck and
Fyn activation [71-73]. Here, an alteration in CD45 ac-
tivity did not appear to be the major cause of the differ-
ential activation of Lck in the two groups of individuals.
Unexpectedly, the levels of CD45 or its activity were
higher in activated T cells of elderly subjects (Figure 4)
but there was no differences in lipid raft location of both
groups of donors. Also, unexpectedly CD45RA expres-
sion and activity did not depend on the age of the sub-
jects, while the expression of CD45RO (marker of
memory T cells) was higher in T cells of elderly. This
may contribute to the increase of the total CD45 expres-
sion and activity at least at 30 s of stimulation (Figure 4A
through C). As there is no clear dichotomy in the role of
CD45 isoforms in reduced T cell activation with aging,
we can hypothesize that the isoform itself has a minimal
importance while the associated signalosome, starting
with Lck activation is more important. We have previ-
ously shown that the formation and composition of
membrane lipid rafts, an important step of cell activa-
tion, are altered in T cells from elderly individuals.
SHP-1 and CD45 play gatekeeper functions as fine
regulators of T cell activation [62,64,73]. Whereas CD45
is generally considered as having a positive and essential
role in T cell activation, SHP-1 acts as a negative feed-
back mechanism by targeting tyrosine-phosphorylated
components associated with the early events of T cell
signaling such as LAT [74], Lck [48], ZAP-70 and the ξ
homodimer [75]. SHP-1-dependent dephosphorylation
of these substrates leads to inhibition of T cell activation.Here, the levels of the active form (Y536) of SHP-1 sig-
nificantly decreased 30 s after TCR-CD28 stimulation of
T cells of young donors (Figure 5), in keeping with posi-
tive Lck upregulation and T cell activation. However, the
active form of SHP-1 returned to elevated levels after
5 min, in agreement with the fact that T cells become
rapidly committed to activation following engagement of
the TCR and CD28. In marked contrast, the levels of
SHP-1-Y536 remained elevated in T cells of elderly indi-
viduals, suggesting that SHP-1 played a negative role in
the early sequence of events leading to activation of T
cells in aged donors. This observation suggested that
SHP-1 remained active under TCR/CD28 stimulation
leading to maintenance of Lck in an inhibitory state. The
interpretation of a persistent dominant negative role of
SHP-1 in T cells of aged donors was further supported
by determination of its activity. SHP-1 activity was simi-
lar in resting T cells of both groups of donors but rapidly
increased and remained high in stimulated T lympho-
cytes of elderly individuals. In contrast, SHP-1 activity
first significantly decreased and became elevated later
(5 min) after activation in lymphocytes of young individ-
uals (Figure 5). SHP-1 is mostly located outside of lipid
rafts in Jurkat T cells but recruitment increases in re-
sponse to protein tyrosine phosphatase inhibition [76].
Furthermore, targeted recruitment of SHP-1 in lipid
rafts results in dephosphorylation of LAT and subse-
quent defects in downstream events of TCR signaling in
Jurkat T cells [74]. Here, results of confocal analysis re-
vealed that SHP-1 was present to the same levels in rest-
ing T cells of young and elderly donors, migrated out of
lipid rafts more importantly in T cells from young sub-
jects than in T cells of elderly after activation, but
returned to lipid rafts over time (Figure 6). Thus, parti-
tioning dynamics of SHP-1 in lipid rafts may to some ex-
tent also contribute to the decreased proliferative
response of T cells of aged individuals, concomitantly
with the much pronounced age-related differences of
SHP-1 activity.
The bulk of the data pointed toward SHP-1 as a key
protein phosphatase that negatively modulated T cell
proliferation in aged individuals. We tested whether
inhibition of SHP-1 would improve the proliferative
response of lymphocytes of elderly individuals to CD3-
CD28 stimulation. As previously reported, T cells of eld-
erly donors displayed an impaired proliferative response
to TCR-CD28-dependent activation and to mitogenic
stimulation (Figure 7A). In marked contrast, treating the
cells with an SHP-1 inhibitor (PTP-1) for 30 s or 30 min
upregulated T cell proliferation to levels that were not
statistically different (one-way ANOVA) than those found
in cells of young donors. The observation that the pres-
ence of PTP-1 did not further increase CD3-CD28-
dependent T cell response of young subjects can be
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thus, on the already maximal proliferation of these cells.
IL-2 production was increased in lymphocytes of aged
donors in experiments using PTP-1 (Figure 7B). These
observations suggested that SHP-1 was a key negative
regulator of the proliferative response of T cells associated
with aging (Figures 7 and 8) and that its inhibition could
efficiently restore two of the most altered functions ob-
served with aging in T cells.
Age-related changes in T cell subset composition in-
volve a reduced frequency/number of naïve T cells, in-
creased number of memory T cells and increased
proportion of CD28- T cells, especially in the CD8+ sub-
population [13]. A decrease in CD28 expression would
affect the efficiency of the co-stimulatory pathway and
this situation has been suggested to be in part respon-
sible for impaired T cell activation with aging [77]. On
the other hand, data from our laboratories have provided
evidence for a direct correlation between the state of ac-
tivation of Lck and LAT and their association/recruit-
ment with lipid rafts of CD4+ and CD8+ T cells [54]. In
relation with these reports, recent data have provided
evidence that, in addition to being a required component
of TCR/CD3 signaling, Lck is an obligatory link for T
cell activation through the CD28 co-stimulatory path-
way. Kong et al. [41] have put forward a model whereby
activated Lck associates with pY207 of the C-terminal
portion of CD28 through its SH2 domain. This associ-
ation retains Lck in lipid rafts and allows its concomitant
interaction with GLK-dependent phosphorylated PKCθ
through its SH3 domain. The model predicts that Lck
therefore provides an essential molecular bridge between
CD28 and PKCθ. Our data suggest that interfering with
the negative regulatory effect of SHP-1 would have a
beneficial effect on signals 1 and 2 of T cell activation
and would help to restore T cell proliferation in aging, as
shown here (Figure 7). Furthermore, it has been recently
reported that impairment of early signalling events in ac-
tivated T cells allows prediction of the levels of expres-
sion of the co-stimulatory molecules CD28 and CD27.
This situation further predicts the number of population
divisions in culture from a limited subset of signalling
molecules such as Lck [78].
Conclusion
Overall, our observations are in agreement with previous
reports that SHP-1 acts as negative regulator of T cell
signaling [52,53,74,75,77,79]. In addition, a recent report
has linked Csk to the termination or control of TCR sig-
naling through modulation of Lck activity [46]. The au-
thors showed that feedback circuits involving Csk, CD45
and, possibly, the inhibitory adaptor protein Dok-1 were
key regulators of the early events of T cell activation.
These circuits could tip the balance in favor of TCRsignaling or an altered response depending on the aging
process. Furthermore, SHP-1 has been reported to be in-
volved in regulation of other cells of the immune system.
For instance, studies of neutrophils have revealed an al-
teration of GM-CSF modulation of SHP-1 with aging
and a defective protection against apoptosis in these
cells which were reversed by inhibition of SHP-1 [67]. In
addition, it has been recently reported that SHP-1 is a
regulator of dendritic cell functions in mice [80,81].
Hyperphosphorylated (active) SHP-1 has recently been
reported to regulate BCR signaling in germinal centers
to favor selection of higher affinity B cells [82], whereas
loss of function in B cells causes systemic autoimmunity
[83]. The bulk of the data presented here are in agree-
ment with the interpretation that the Csk/PAG loop and
SHP-1 are key negative participants of T cell functions
in aging since this negative influence cannot be relieved
by TCR/CD28 stimulation (Figure 9). The successful im-
provement of T cell functions in T cells of elderly donors
by inhibiting the SHP-1 activity can be a powerful im-
munomodulatory tool and requires further investiga-
tions. One limitation of the present study is that it
cannot discern between internal T cell changes and
changes due to the relative abundance of T cell subsets
with aging. In particular, it is important to point out that
the present study cannot determine if the effect ob-
served is specific for a particular subset of T cells [84]
even if our preliminary data suggest that the CD45RA or
CD45RO T cell subpopulations cannot explain these
changes. Nevertheless, the data provide support for a
key role of Lck in the altered response of T cells in
aging, revealing additional clues to unravel the under-
lying mechanisms of immunosenescence which are
under current investigations in our laboratories, espe-
cially addressing this question in T cell subpopulations.
Materials and methods
Antibodies and reagents
Polyclonal antibodies (pAbs) anti-PAG (sc-25748), -Lck (sc-
28882), -Csk (sc-286), -SHP-1 (sc-287), -CD45 (sc-1178),
-CD45RA (sc-19664), -CD45RO (sc-70712) and -β-actin
(sc-1616) were from Santa Cruz Biotechnology (Santa
Cruz, CA). Anti-CD3 (clone UCHT1) and anti-CD28
(clone CD28.2) monoclonal antibodies (mAbs) were
from BD Biosciences (Mississauga, ON). pAbs anti-
phospho-PAG (Y763) (ab18030) and anti-PAG (ab56521) were
from Abcam (Cambridge, MA). An anti-phospho-Tyr505
(2751S) Lck Ab was from Cell Signaling Technology
Inc. (Pickering, ON) whereas an anti-phospho-Tyr394
(SAB4300118) Lck Ab was from Sigma-Aldrich. The
anti-phospho-Tyr536 SHP-1 mAb was from ECM Bio-
sciences (Versailles, KY). A FITC-conjugated anti-IL-2
mAb (clone M1Q_17H12) was purchased from BD
Biosciences. The SHP-1 PTP inhibitor I (PTP-I,
A B
Figure 9 Minimal model summarizing the roles of SHP-1 and PAG in negative regulation of T cell response in aging. A) The model
proposes that in T cells of young individuals, ligation of the TCR and CD28 leads to activation (TCR/CD28*) and concomitant up-regulation of Lck
activity resulting from dephosphorylation of Y505, subsequent release of self-inhibition and activation following autophosphorylation at position
Y394. Activation of pLck leads to phosphorylation of ITAM motifs of CD3 and the ζ homodimer, triggering the early events of signal transduction.
Data reported here showed that the activity of pSHP-1 in T cells of young subjects was transiently low following T cell activation, whereas pPAG
transiently migrated out of lipid rafts. These combined events would favor maintaining upregulation of Lck activity which would fulfill the
requirements of Signal 1 of T cell activation. Initiation of the Signal 2 leads to full T cell response. B) A similar series of events occurs in T cells of
elderly individuals. However, data reported here showed that the activity of pSHP-1 was sustained in these cells and that pPAG was retained in
lipid rafts thus contributing to sustained elevated Csk activity. These combined events would lead to lowered activity of pLck, a decrease of the
strength of Signal 1 and, an overall decrease of T cell activation. These conditions lead to a diminished T cell response that contributes
to immunosenescence.
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Chemicals Inc., Gibbstown, NJ). Alexa Fluor 488-labelled
cholera toxin B subunit and Alexa Fluor 568-labelled goat
anti-rabbit IgG were purchased from Invitrogen (Carlsbad,
CA). RPMI-1640 culture medium was obtained from Wisent
Inc. (St Bruno, QC), whereas Ficoll Paque plus and Dextran
T-500 were from GE Healthcare (Piscataway, NJ). Protein
A/G-bound Sepharose was obtained from BioVision Inc.
(Milpitas, CA). A Western lightning Plus ECL kit and
PVDF membranes were purchased from PerkinElmer
(Waltham, MA). Reagents for SDS-PAGE were from Bio-
Rad (Richmond, CA) and Fisher Scientific (Montreal, QC).
Subjects
Twenty five healthy elderly volunteers aged 65 to 78 years
(mean, 73 years) participated in the study. The cohort of
25 young healthy subjects was 19 to 25 year old (mean, 22
years). The research protocol was approved by the local in-
stitutional ethics committee of the Research Center on
Aging. All subjects gave written informed consent. The
volunteers were in good health, normolipemic and satisfied
the inclusion criteria of the SENIEUR protocol for immune
investigations of human elderly subjects [85]. Individualexperiments were performed in parallel (on the same day),
that is by collecting blood samples from the same number
of healthy young donors and healthy aged donors.
Isolation of PBMCs
Blood obtained by venipuncture was collected in heparin-
ized tubes and diluted two-fold with phosphate-buffered
saline (PBS). PBMCs were isolated by Ficoll Paque plus
density sedimentation, as described [56]. The buffy coat
was recovered, the cells were washed (PBS) and counted.
Cell viability was greater than 95% (Trypan blue exclu-
sion). Identical numbers of cells from young and aged do-
nors were used in each comparative experiment.
T cells purification
PBMCs were freed of monocyte by adhesion to plastic tis-
sue culture flasks coated with autologous serum (1 h, 37°C)
and, B cells and phagocytic cells by nylon wool retention,
as described [86]. Purified T cells were greater than 98%
CD3+ cells with less than 1% surface IgM (B cells)-, CD16
(NK cells)- and CD14 (monocytes)-positive contaminating
cells as verified by FACScan (FACSCalibur). Cell viability
was greater than 97% (Trypan blue exclusion). Identical
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in each comparative experiment.
Lymphocyte proliferation
PBMCs (2 × 105 cells/well) were exposed to anti-CD3
(5 μg/ml) and/or anti-CD28 (5 μg/ml) for 72 h in 96 well
flat-bottomed microcultures (Microtest, Becton Dickinson)
in a final volume of 200 μl of RPMI 1640 medium con-
taining 10% foetal bovine serum (FBS), streptomycin
(100 μg/ml) and penicillin G (100 U/ml) at 37°C in an
atmosphere of 95% air, 5% CO2 and 90% relative humi-
dity. Cell proliferation was quantitated by measuring [3H]
thymidine incorporation, as described [55].
Isolation of lipid rafts
T cells were kept for 1 h in RPMI medium at 37°C. The
cells (20 × 106 lymphocytes) were then exposed to a
combination of anti-CD3 (5 μg/ml) and anti-CD28
(5 μg/ml) mAb for various periods of time at 37°C, as
described [63] or were left untreated (control). Lipid raft
isolation on sucrose density gradients (9 fractions) was
done as already described [87]. Lipid rafts were distrib-
uted in fractions 1 to 3 of the gradient whereas non-
lipid rafts corresponded to fractions 7 to 9. Western
blotting analyses were done using pooled lipid raft and
non-lipid raft fractions.
Western blots
Proteins from total cell lysates (20 μg) or pooled lipid
raft fractions (30 μl) were sized by SDS-PAGE under re-
ducing conditions, transferred to PVDF membranes and
revealed by Western blotting, as described [63,87].
Acrylamide concentration was 10% in SDS-PAGE ana-
lysis performed under reducing conditions, according to
Laemmli [88]. To reveal β-actin, PVDF membranes were
stripped of antibody by washing (twice, 5 min) with
TBST buffer (20 mM TRIS, 150 mM NaCl, 0.1% Tween
20, pH 7.4), incubation with PBS (pH 2.0, ajusted with
HCl) for 40 min at 65°C, followed by washing (twice,
5 min) with TBST. The membrane was then probed
with an anti-actin antibody. Densitometric analyses
were performed using the image analyzer Chemigenius2
Bio Imaging System (Syngene, Frederick, MD) or the
Java-based ImageJ freeware (http://rsbweb.nih.gov/ij/).
All blots were first normalized towards actin and then
to the non-phosphorylated form of the studied protein.
Confocal microscopy analysis
T cells in RPMI 1640 medium containing 10% FBS were
exposed to a combination of anti-CD3 (5 μg/ml) and anti-
CD28 (5 μg/ml) mAbs for various periods of time at 37°C.
Stimulation was terminated by centrifugation, the cells
were washed with culture medium and then incubated for
30 min (4°C) with Alexa Fluor 488-conjugated choleratoxin B subunit. They were then fixed with 4% parafor-
maldehyde in PBS for 15 min on ice. After a wash with
cold PBS, the cells were incubated for 1 h at room
temperature in the presence of the relevant primary
antibodies in PBS containing 1% skimmed powdered
milk, 1.4% bovine serum albumin (BSA) and 0.1% Tri-
ton X-100. T cells were then washed with PBS and incu-
bated in the same solution containing the secondary Ab
(Alexa Fluor 568-labelled goat anti-rabbit IgG) for 1 h
at room temperature. After washing with ice-cold PBS,
the cells were placed on microscope slides and mounted
with Vectashield Mounting Medium (Vector Laborator-
ies, Burlington, ON). Scanning confocal microscope
analysis were done as published using a FV1000 instru-
ment (Olympus, Tokyo, Japan) coupled to an inverted
Olympus microscope with a 63X oil immersion objective
[87]. Specimens were laser-excited at 488 nm (40 mW
argon laser) and 563 nm (helium-neon laser). Serial hori-
zontal optical sections of 512 x 512 pixels were taken at
0.5 μm intervals through the entire thickness of the cell.
Images were acquired typically from 10–15 cells of similar
size from each experimental condition using identical set-
tings of the instrument. In the case of Alexa 488/Alexa
563-merged fluorescence images, dot fluorograms were
obtained by plotting pixel values of each fluorochrome
toward the horizontal and vertical axis, respectively.
Quadrant markers were used to separate staining in back-
ground pixels (C, lower left), red-only pixels (A, upper
left), green-only pixels (D, lower right) and co-localizing
pixels (B, upper right). Percentage of colocalization was
assessed as follows: (number of pixels in quadrant B)/
(number of pixels in quadrant B + number of pixels in
quadrant D). Images were contrast-enhanced, pseudoco-
lored according to their original fluorochromes, merged
(co-localizing green and red pixels are in yellow pseucolor
in the Figures), cropped and then assembled using the
FluoView version 3.1 software (Olympus, Tokyo).
Protein tyrosine phosphatase assays
T cells (5 x 106 cells/ml) in RPMI 1640 medium were left
untreated or treated with PTP-1 for different periods of
time, as follows. In the cases of short time experiments
(30 s and 5 min), the cells were distributed in Eppendorf
tubes (2 ml of cell suspension/tube) and PTP-1 was
added to a final concentration of 50 ng/ml. For each set
of experiments, T cells were centrifuged, washed and
suspended in RPMI 1640 medium (10 x 106 cells/ml)
and exposed to a mixture of anti-CD3 (5 μg/ml) and
anti-CD28 (5 μg/ml) mAbs for the times indicated in the
relevant Figures. In the cases of long time experiments
(30 min), PTP-1 treatments were done with cells resting
in 6-well culture plates (10 x 106 cells/well) containing
2 ml of culture medium in each well. At the end of the
treatment, lymphocytes were retrieved, centrifuged and
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scribed above. The cells were then washed with PBS,
and resuspended in ice-cold lysis buffer (150 mM NaCl,
10 mM EGTA, 5 mM EDTA, 1 mM phenylmethylsulfo-
nyl fluoride (PMSF), 10 mM sodium polyphosphate, 1%
Nonidet P-40 (NP-40) and antiproteases cocktail in
50 mM (4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES), pH 7.4) for 30 min at 4°C, with periodic
gentle shaking. Lysates were cleared by centrifugation
(13,000 rpm). Samples containing 120 μg of proteins
were retrieved and volume completed to 350 µl Protein
A/G-bound Sepharose (20 μl) beads were added for pre-
clearing. The mixture was gently rocked for 30 min at
4°C mAbs directed against SHP-1 or CD45 or CD45RA
or CD45RO (2 μg/experimental condition) were added
to the supernatants, followed by incubation overnight at
4°C under gentle rocking (2 μg/experimental condition).
Protein A/G-bound Sepharose (35 μl) beads were added,
and incubations under gentle rocking were performed
for 4 h at 4°C. The beads were washed with buffer
(150 mM NaCl, 10 mM EGTA, 5 mM EDTA and 0.1%
NP-40 in 5 mM Tris.HCl buffer, pH 7.5) and subjected to
phosphatase assays. Briefly, the beads were washed once
with assay buffer (0.5 mM EGTA in 25 mM HEPES,
pH 7.0) and then incubated with 200 μl of the same buffer
containing 10 mM 4-nitrophenyl phosphate at 37°C for
4 h with periodic mixing. Reactions were stopped by
addition of 0.2 M NaOH (800 μl), beads were removed
by brief centrifugation, supernatants were distributed
in 96-well plates and absorbance was read at 405 nm
using a Victor X5 2030 Multilabeled reader (PerkinElmer
(Waltham, MA). Equal amounts of proteins (Bradford’s re-
agent, Bio-Rad, Richmond, CA) from young and elderly
donor aliquots were used in CD45, CD45RA, CD45RO
and SHP-1 phosphatase assays, as already described [67]
as verified also by Ponceau staining.
Measurement of intracellular IL-2
PBMCs (1 x 106 cells/ml) in RPMI 1640 medium were
left untreated or treated with PTP-1 for different periods
of time, as described for protein phosphatase assays.
They were stimulated using a combination of anti-CD3
(5 μg/ml) and anti-CD28 (5 μg/ml) mAbs for the times
indicated in the legend of the Figure. In the case of each
experiments, the cells were placed in Eppendorf tubes,
washed by brief centrifugation with cold PBS, fixed by
treatment (20 min in the dark, 4°C) with 250 μl of 4%
(w/v) paraformaldehyde (BioLegend, Burlington, ON)
and then washed with a mixture of PBS (1 ml) and di-
luted (PBS) permeabilization buffer (250 μl) containing
FBS and saponin (PermWash buffer, BD Pharmingen).
After washings, staining was done with permeabilization
wash buffer (200 μl) containing a FITC-conjugated rat
anti-human IL-2 Ab (0.2 μg/ml) for 30 min at 4°C, inthe dark as already described [56]. The stained cells were
washed once with permeabilization wash buffer and re-
suspended in PBS (250 μl). The cells were analyzed
within 24 h by flow cytometry using a FACSCalibur in-
strument (Beckton Dickinson). A minimum of 10,000
events were acquired in each analysis.
Flow Cytometry measurement of pLck-Y505 and pSHP1-
Y536 in T cells after TCR/CD28 stimulation
After stimulation for 0, 30 s and 5 minutes, cells (1 x106)
were suspended into 500 μL of PBS 1X at room temperature
(RT), and fixed 10 minutes in the dark at room tem-
perature (RT) with 1% paraformaldehyde pre-warmed
(Biolegend, Burlington, ON). Then cells were saturated
by an incubation of 10 minutes with 10% PBS-AB-human
serum (Life technologies). After two washings, a 30 mi-
nutes surface staining was made with anti-CD3 Alexa700,
CD45RA BV421, and CD45R0 FITC (BD Biosciences,
Mississauga, ON). After two washings and vortex of the
sediment, 1 mL of BD Phosflow Perm Buffer III was added
and incubated for 30 minutes at 4°C. Three washing with
3 mL of PBS was performed before starting 1 hour of intra-
cellular staining at RT in the dark. Antibodies used were:
pLckY505 Alexa Fluor 647 (BD Biosciences, Mississauga,
ON) and pSHP1 (ECM Biosciences, Versailles, KY) with
anti-rabbit IgG PE (Ebioscience, San Diego, CA) were
used. The second intracellular staining with anti-rabbit
IgG PE was made 1 hour at RT in the dark. After washing,
cells were ready to be analysed on a FACS Aria III cyt-
ometer (BD Biosciences).
Statistical analyses
Data were analyzed using Student’s t-test and one-way
ANOVA (SigmaStat software, Systat Software Inc.,
Chicago, IL).
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